跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,415 条关于
“p38 MAP kinase”
全部
8,415
临床试验
4,542
药物
1,194
机构
66
资讯
2,613
8天前
CervoMed's Neflamapimod Phase 2a Biomarker Data in nfvPPA Selected for Late-Breaking ISFTD Presentation
10个月前
Poolbeg Pharma Secures European Patent for POLB 001 Targeting Severe Influenza and Cancer Immunotherapy Side Effects
9个月前
Poolbeg Pharma's POLB 001 Takes Center Stage in £3.4 Million CRS Prevention Research Programme
去年
FDA Grants Orphan Drug Designation to Poolbeg Pharma's POLB 001 for Cancer Immunotherapy-Induced Cytokine Release Syndrome
9个月前
Ipsen Expands Oncology Partnership with Université de Montréal and IRICoR, Adding Two MAP Kinase-Related Discovery Programs
去年
CervoMed's Neflamapimod Shows Promise in Dementia with Lewy Bodies
去年
JAK Inhibitor Pipeline Shows Promise for Autoimmune and Inflammatory Diseases
6年前
CDK4/6 Inhibitors Plus Endocrine Therapy Improves Survival in HR+/HER2- Advanced Breast Cancer
6年前
CDK4/6 Inhibitors Plus Endocrine Therapy Significantly Improve Outcomes in Advanced Breast Cancer
10个月前
BriaCell Partners with Receptor.AI to Develop AI-Driven Cancer Kinase Inhibitors
第 1 页,共 262 页
上一页
下一页